I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 1978

R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati

Insulin response and FFA behavior have been evaluated during an IVGTT in 63 subjects of whom 18 were normal, 31 were obese (with varying degrees of carbohydrate tolerance) and 14 were mild non insulin-dependent diabetics. The extreme reduction of insulin secretion in the early phase (delta 0-15 min) and the less severe impairment of the late phase (delta 15-60 min) have been confirmed; obese subjects showed on the average an active insulin response to venous loading; this was more marked and more consistent in the late phase. Compared to controls, FFA concentration both in basal conditions and during IVGTT was progressively higher in obese and diabetic patients. When analyzing the interplay between IRI, KG and FFA in the course of IVGTT, it was observed that: (1) a close correlation exists between IG and early insulin response (r = 0.72); (2) a correlation between delta IRI 0-15 min and percentage decrease of FFA at 45 min is found only in normal subjects; (3) a negative highly significant correlation is found between KG and mean FFA plasma level 0-60 min. This last correlation is evidence of the important role played by FFA in carbohydrate tolerance. The conflicting results reported by others have been discussed.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
July 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
February 1974, Nihon Naibunpi Gakkai zasshi,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
May 1979, Minerva medica,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
May 1979, Minerva medica,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
January 1984, Acta diabetologica latina,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
July 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
January 1954, Acta medica Patavina,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
January 1991, Recenti progressi in medicina,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
April 1971, The Quarterly journal of medicine,
R Prando, and R Cordera, and A De Micheli, and M Maiello, and P Odetti, and G Viviani, and L Corsi, and L Adezati
February 1976, The New England journal of medicine,
Copied contents to your clipboard!